All of DSpace

Browsing by Subject "malignant neoplasm"

Now showing items 21-40 of 48

    • Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015 

      Barber R.M., Fullman N., Sorensen R.J.D., Bollyky T., McKee M., Nolte E., Abajobir A.A., Abate K.H., Abbafati C., Abbas K.M., Abd-Allah F., Abdulle A.M., Abdurahman A.A., Abera S.F., Abraham B., Abreha G.F., Adane K., Adelekan A.L., Adetifa I.M.O., Afshin A., Agarwal A., Agarwal S.K., Agarwal S., Agrawal A., Ahmad Kiadaliri A., Ahmadi A., Ahmed K.Y., Ahmed M.B., Akinyemi R.O., Akinyemiju T.F., Akseer N., Al-Aly Z., Alam K., Alam N., Alam S.S., Alemu Z.A., Alene K.A., Alexander L., Ali R., Ali S.D., Alizadeh-Navaei R., Alkerwi A., Alla F., Allebeck P., Allen C., Al-Raddadi R., Alsharif U., Altirkawi K.A., Alvarez Martin E., Alvis-Guzman N., Amare A.T., Amini E., Ammar W., Amo-Adjei J., Amoako Y.A., Anderson B.O., Androudi S., Ansari H., Ansha M.G., Antonio C.A.T., Ärnlöv J., Artaman A., Asayesh H., Assadi R., Astatkie A., Atey T.M., Atique S., Atnafu N.T., Atre S.R., Avila-Burgos L., Avokpaho E.F.G.A., Ayala Quintanilla B.P., Awasthi A., Ayele N.N., Azzopardi P., Ba Saleem H.O., Bärnighausen T., Bacha U., Badawi A., Banerjee A., Barac A., Barboza M.A., Barker-Collo S.L., Barrero L.H., Basu S., Baune B.T., Baye K., Bayou Y.T., Bazargan-Hejazi S., Bedi N., Beghi E., Béjot Y., Bello A.K., Bennett D.A., Bensenor I.M., Berhane A., Bernabé E., Bernal O.A., Beyene A.S., Beyene T.J., Bhutta Z.A., Biadgilign S., Bikbov B., Birlik S.M., Birungi C., Biryukov S., Bisanzio D., Bizuayehu H.M., Bose D., Brainin M., Brauer M., Brazinova A., Breitborde N.J.K., Brenner H., Butt Z.A., Cárdenas R., Cahuana-Hurtado L., Campos-Nonato I.R., Car J., Carrero J.J., Casey D., Caso V., Castañeda-Orjuela C.A., Castillo Rivas J., Catalá-López F., Cecilio P., Cercy K., Charlson F.J., Chen A.Z., Chew A., Chibalabala M., Chibueze C.E., Chisumpa V.H., Chitheer A.A., Chowdhury R., Christensen H., Christopher D.J., Ciobanu L.G., Cirillo M., Coggeshall M.S., Cooper L.T., Cortinovis M., Crump J.A., Dalal K., Danawi H., Dandona L., Dandona R., Dargan P.I., Das Neves J., Davey G., Davitoiu D.V., Davletov K., De Leo D., Del Gobbo L.C., Del Pozo-Cruz B., Dellavalle R.P., Deribe K., Deribew A., Des Jarlais D.C., Dey S., Dharmaratne S.D., Dicker D., Ding E.L., Dokova K., Dorsey E.R., Doyle K.E., Dubey M., Ehrenkranz R., Ellingsen C.L., Elyazar I., Enayati A., Ermakov S.P., Eshrati B., Esteghamati A., Estep K., Fürst T., Faghmous I.D.A., Fanuel F.B.B., Faraon E.J.A., Farid T.A., Farinha C.S.E.S., Faro A., Farvid M.S., Farzadfar F., Feigin V.L., Feigl A.B., Fereshtehnejad S.-M., Fernandes J.G., Fernandes J.C., Feyissa T.R., Fischer F., Fitzmaurice C., Fleming T.D., Foigt N., Foreman K.J., Forouzanfar M.H., Franklin R.C., Frostad J., Ghiwot T.T., Gakidou E., Gambashidze K., Gamkrelidze A., Gao W., Garcia-Basteiro A.L., Gebre T., Gebremedhin A.T., Gebremichael M.W., Gebru A.A., Gelaye A.A., Geleijnse J.M., Genova-Maleras R., Gibney K.B., Giref A.Z., Gishu M.D., Giussani G., Godwin W.W., Gold A., Goldberg E.M., Gona P.N., Goodridge A., Gopalani S.V., Goto A., Graetz N., Greaves F., Griswold M., Guban P.I., Gugnani H.C., Gupta P.C., Gupta R., Gupta R., Gupta T., Gupta V., Habtewold T.D., Hafezi-Nejad N., Haile D., Hailu A.D., Hailu G.B., Hakuzimana A., Hamadeh R.R., Hambisa M.T., Hamidi S., Hammami M., Hankey G.J., Hao Y., Harb H.L., Hareri H.A., Haro J.M., Hassanvand M.S., Havmoeller R., Hay R.J., Hay S.I., Hendrie D., Heredia-Pi I.B., Hoek H.W., Horino M., Horita N., Hosgood H.D., Htet A.S., Hu G., Huang H., Huang J.J., Huntley B.M., Huynh C., Iburg K.M., Ileanu B.V., Innos K., Irenso A.A., Jahanmehr N., Jakovljevic M.B., James P., James S.L., Javanbakht M., Jayaraman S.P., Jayatilleke A.U., Jeemon P., Jha V., John D., Johnson C., Johnson S.C., Jonas J.B., Juel K., Kabir Z., Kalkonde Y., Kamal R., Kan H., Karch A., Karema C.K., Karimi S.M., Kasaeian A., Kassebaum N.J., Kastor A., Katikireddi S.V., Kazanjan K., Keiyoro P.N., Kemmer L., Kemp A.H., Kengne A.P., Kerbo A.A., Kereselidze M., Kesavachandran C.N., Khader Y.S., Khalil I., Khan A.R., Khan E.A., Khan G., Khang Y.-H., Khoja A.T.A., Khonelidze I., Khubchandani J., Kibret G.D., Kim D., Kim P., Kim Y.J., Kimokoti R.W., Kinfu Y., Kissoon N., Kivipelto M., Kokubo Y., Kolk A., Kolte D., Kopec J.A., Kosen S., Koul P.A., Koyanagi A., Kravchenko M., Krishnaswami S., Krohn K.J., Kuate Defo B., Kucuk Bicer B., Kuipers E.J., Kulkarni V.S., Kumar G.A., Kumsa F.A., Kutz M., Kyu H.H., Lager A.C.J., Lal A., Lal D.K., Lalloo R., Lallukka T., Lan Q., Langan S.M., Lansingh V.C., Larson H.J., Larsson A., Laryea D.O., Latif A.A., Lawrynowicz A.E.B., Leasher J.L., Leigh J., Leinsalu M., Leshargie C.T., Leung J., Leung R., Levi M., Liang X., Lim S.S., Lind M., Linn S., Lipshultz S.E., Liu P., Liu Y., Lo L.-T., Logroscino G., Lopez A.D., Lorch S.A., Lotufo P.A., Lozano R., Lunevicius R., Lyons R.A., Macarayan E.R.K., Mackay M.T., Magdy Abd El Razek H., Magdy Abd El Razek M., Mahdavi M., Majeed A., Malekzadeh R., Malta D.C., Mantovani L.G., Manyazewal T., Mapoma C.C., Marcenes W., Marks G.B., Marquez N., Martinez-Raga J., Marzan M.B., Massano J., Mathur M.R., Maulik P.K., Mazidi M., McAlinden C., McGrath J.J., McNellan C., Meaney P.A., Mehari A., Mehndiratta M.M., Meier T., Mekonnen A.B., Meles K.G., Memish Z.A., Mengesha M.M., Mengiste D.T., Mengistie M.A., Menota B.G., Mensah G.A., Mereta S.T., Meretoja A., Meretoja T.J., Mezgebe H.B., Micha R., Millear A., Mills E.J., Minnig S., Mirarefin M., Mirrakhimov E.M., Mock C.N., Mohammad K.A., Mohammed S., Mohanty S.K., Mokdad A.H., Mola G.L.D., Molokhia M., Monasta L., Montico M., Moradi-Lakeh M., Moraga P., Morawska L., Mori R., Moses M., Mueller U.O., Murthy S., Musa K.I., Nachega J.B., Nagata C., Nagel G., Naghavi M., Naheed A., Naldi L., Nangia V., Nascimento B.R., Negoi I., Neupane S.P., Newton C.R., Ng M., Ngalesoni F.N., Ngunjiri J.W., Nguyen G., Ningrum D.N.A., Nolte S., Nomura M., Norheim O.F., Norrving B., Noubiap J.J.N., Obermeyer C.M., Ogbo F.A., Oh I.-H., Okoro A., Oladimeji O., Olagunju A.T., Olivares P.R., Olsen H.E., Olusanya B.O., Olusanya J.O., Opio J.N., Oren E., Ortiz A., Osborne R.H., Osman M., Owolabi M.O., Mahesh P.A., Pain A.W., Pakhale S., Palomares Castillo E., Pana A., Papachristou C., Parsaeian M., Patel T., Patton G.C., Paudel D., Paul V.K., Pearce N., Pereira D.M., Perez-Padilla R., Perez-Ruiz F., Perico N., Pesudovs K., Petzold M., Phillips M.R., Pigott D.M., Pillay J.D., Pinho C., Polinder S., Pond C.D., Prakash V., Purwar M., Qorbani M., Quistberg D.A., Radfar A., Rafay A., Rahimi K., Rahimi-Movaghar V., Rahman M., Rahman M.H.U., Rai R.K., Ram U., Rana S.M., Rankin Z., Rao P.V., Rao P.C., Rawaf S., Rego M.A.S., Reitsma M., Remuzzi G., Renzaho A.M.N.N., Resnikoff S., Rezaei S., Rezai M.S., Ribeiro A.L., Roba H.S., Rokni M.B., Ronfani L., Roshandel G., Roth G.A., Rothenbacher D., Roy N.K., Sachdev P.S., Sackey B.B., Saeedi M.Y., Safiri S., Sagar R., Sahraian M.A., Saleh M.M., Salomon J.A., Samy A.M., Sanabria J.R., Sanchez-Niño M.D., Sandar L., Santos I.S., Santos J.V., Santric Milicevic M.M., Sarmiento-Suarez R., Sartorius B., Satpathy M., Savic M., Sawhney M., Saylan M.I., Schöttker B., Schutte A.E., Schwebel D.C., Seedat S., Seid A.M., Seifu C.N., Sepanlou S.G., Serdar B., Servan-Mori E.E., Setegn T., Shackelford K.A., Shaheen A., Shahraz S., Shaikh M.A., Shakh-Nazarova M., Shamsipour M., Shariful Islam S.M., Sharma J., Sharma R., She J., Sheikhbahaei S., Shen J., Shi P., Shigematsu M., Shin M.-J., Shiri R., Shoman H., Shrime M.G., Sibamo E.L.S., Sigfusdottir I.D., Silva D.A.S., Silveira D.G.A., Sindi S., Singh A., Singh J.A., Singh O.P., Singh P.K., Singh V., Sinke A.H., Sinshaw A.E., Skirbekk V., Sliwa K., Smith A., Sobngwi E., Soneji S., Soriano J.B., Sousa T.C.M., Sposato L.A., Sreeramareddy C.T., Stathopoulou V., Steel N., Steiner C., Steinke S., Stokes M.A., Stranges S., Strong M., Stroumpoulis K., Sturua L., Sufiyan M.B., Suliankatchi R.A., Sun J., Sur P., Swaminathan S., Sykes B.L., Tabarés-Seisdedos R., Tabb K.M., Taffere G.R., Talongwa R.T., Tarajia M., Tavakkoli M., Taveira N., Teeple S., Tegegne T.K., Tehrani-Banihashemi A., Tekelab T., Tekle D.Y., Temam Shifa G., Terkawi A.S., Tesema A.G., Thakur J.S., Thomson A.J., Tillmann T., Tiruye T.Y., Tobe-Gai R., Tonelli M., Topor-Madry R., Tortajada M., Troeger C., Truelsen T., Tura A.K., Uchendu U.S., Ukwaja K.N., Undurraga E.A., Uneke C.J., Uthman O.A., Van Boven J.F.M., Van Dingenen R., Varughese S., Vasankari T., Venketasubramanian N., Violante F.S., Vladimirov S.K., Vlassov V.V., Vollset S.E., Vos T., Wagner J.A., Wakayo T., Waller S.G., Walson J.L., Wang H., Wang Y.-P., Watkins D.A., Weiderpass E., Weintraub R.G., Wen C.-P., Werdecker A., Wesana J., Westerman R., Whiteford H.A., Wilkinson J.D., Wiysonge C.S., Woldeyes B.G., Wolfe C.D.A., Won S., Workicho A., Workie S.B., Wubshet M., Xavier D., Xu G., Yadav A.K., Yaghoubi M., Yakob B., Yan L.L., Yano Y., Yaseri M., Yimam H.H., Yip P., Yonemoto N., Yoon S.-J., Younis M.Z., Yu C., Zaidi Z., El Sayed Zaki M., Zambrana-Torrelio C., Zapata T., Zenebe Z.M., Zodpey S., Zoeckler L., Zuhlke L.J., Murray C.J.L., GBD 2015 Healthcare Access and Quality Collaborators (2017)
      Background National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality). ...

    • HOTAIR as a prognostic predictor for diverse human cancers: A meta- and bioinformatics analysis 

      Toy H.I., Okmen D., Kontou P.I., Georgakilas A.G., Pavlopoulou A. (2019)
      Several studies suggest that upregulated expression of the long non-coding RNA HOX transcript antisense RNA (HOTAIR) is a negative predictive biomarker for numerous cancers. Herein, we performed a meta-analysis to further ...

    • Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach 

      Nikolaou M., Nikolaou G., Digklia A., Pontas C., Tsoukalas N., Kyrgias G., Tolia M. (2019)
      Oncology is currently a sector of medical science with accelerated progress due to rapid technological development, the advancement in molecular biology, and the invention of many innovative therapies. Immunotherapy partially ...

    • Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis 

      Kountouras J., Boziki M., Polyzos S.A., Katsinelos P., Gavalas E., Zeglinas C., Tzivras D., Romiopoulos I., Giorgakis N., Anastasiadou K., Vardaka E., Kountouras C., Kazakos E., Xiromerisiou G., Dardiotis E., Deretzi G. (2017)
      Helicobacter pylori (H. pylori) induces reactive oxygen species (ROS) production that contribute to pathogenesis of a variety of H. pylori-related gastric diseases, as shown in animal and human studies. Helicobacter pylori ...

    • Lipid Metabolism in Cancer: The Role of Acylglycerolphosphate Acyltransferases (AGPATs) 

      Karagiota A., Chachami G., Paraskeva E. (2022)
      Altered lipid metabolism is an emerging hallmark of aggressive tumors, as rapidly proliferating cancer cells reprogram fatty acid (FA) uptake, synthesis, storage, and usage to meet their increased energy demands. Central ...

    • Lncrnas as chromatin regulators in cancer: From molecular function to clinical potential 

      Begolli R., Sideris N., Giakountis A. (2019)
      During the last decade, high-throughput sequencing efforts in the fields of transcriptomics and epigenomics have shed light on the noncoding part of the transcriptome and its potential role in human disease. Regulatory ...

    • Low-Protein Diet Induces IRE1α-Dependent Anticancer Immunosurveillance 

      Rubio-Patiño C., Bossowski J.P., De Donatis G.M., Mondragón L., Villa E., Aira L.E., Chiche J., Mhaidly R., Lebeaupin C., Marchetti S., Voutetakis K., Chatziioannou A., Castelli F.A., Lamourette P., Chu-Van E., Fenaille F., Avril T., Passeron T., Patterson J.B., Verhoeyen E., Bailly-Maitre B., Chevet E., Ricci J.-E. (2018)
      Dietary restriction (DR) was shown to impact on tumor growth with very variable effects depending on the cancer type. However, how DR limits cancer progression remains largely unknown. Here, we demonstrate that feeding ...

    • The management of atrial fibrillation in heart failure: an expert panel consensus 

      Farmakis D., Chrysohoou C., Giamouzis G., Giannakoulas G., Hamilos M., Naka K., Tzeis S., Xydonas S., Karavidas A., Parissis J. (2021)
      Heart failure (HF) and atrial fibrillation (AF) often coexist, being closely interrelated as the one increases the prevalence and incidence and worsens the prognosis of the other. Their frequent coexistence raises several ...

    • Medical misinformation in mass and social media: An urgent call for action, especially during epidemics 

      Chrousos G.P., Mentis A.-F.A. (2020)
      [No abstract available]

    • Mortality and morbidity from infectious and non-communicable diseases in Greece during Axis/Nazi military occupation (1941-1944) 

      Rachiotis G., Papagiannis D., Dardavesis T., Behrakis P. (2022)
      Greece has been severely damaged by the Second World War and the subsequent military occupation of the country by the Axis forces headed by Nazi Germa-ny. The Greek society and economy were dislocated as a result of ...

    • New prophylaxis strategies to reduce the risk of thromboembolism in cancer 

      Papadopoulos V., Tsapakidis K., Markou A., Kokkalis A., Aidarinis C., Kotsakis A. (2021)
      Introduction: Patients with cancer are at risk of thrombotic events, mainly deep vein thrombosis and/or pulmonary embolism. The thrombosis risk is generally 4–6 times higher than in a healthy population and depends on ...

    • Patient and family support in the era of fake e-medicine: Food for thought from an international consensus panel 

      Mauri D., Kamposioras K., Tzachanis D., Tolia M., Valachis A., Dambrosio M., Alongi F., De Mello R.A., Lövey J., Anthoney A., Christopoulos C., Saraireh H.H., Kountourakis P., Kampletsas E., Tsali L., Tsakiridis T., Kosovitsas I., Soukovelos A., Lymperatou D., Polyzos N., Zarkavelis G. (2020)
      [No abstract available]

    • Plasmir: A manual collection of circulating micrornas of prognostic and diagnostic value 

      Tastsoglou S., Miliotis M., Kavakiotis I., Alexiou A., Gkotsi E.C., Lambropoulou A., Lygnos V., Kotsira V., Maroulis V., Zisis D., Skoufos G., Hatzigeorgiou A.G. (2021)
      Only recently, microRNAs (miRNAs) were found to exist in traceable and distinctive amounts in the human circulatory system, bringing forth the intriguing possibility of using them as minimally invasive biomarkers. miRNAs ...

    • Position Statement on Exercise Dosage in Rheumatic and Musculoskeletal Diseases: The role of the IMPACT-RMD Toolkit 

      Metsios G.S., Brodin N., Vlieland T.P.M.V., Ende C.H.M.V.D., Stavropoulos-Kalinoglou A., Fatouros I., van der Esch M., Fenton S.A.M., Tzika K., Moe R.H., van Zanten J.J.C.S.V., Koutedakis Y., Swinnen T.W., Veskoukis A.S., Boström C., Kennedy N., Nikiphorou E., Fragoulis G.E., Niedermann K., Kitas G.D. (2021)
      There is convincing evidence to suggest that exercise interventions can significantly improve disease-related outcomes as well as comorbidities in rheumatic and musculoskeletal diseases (RMDs). All exercise interventions ...

    • Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry 

      Giannis D., Allen S.L., Tsang J., Flint S., Pinhasov T., Williams S., Tan G., Thakur R., Leung C., Snyder M., Bhatia C., Garrett D., Cotte C., Isaacs S., Gugerty E., Davidson A., Marder G.S., Schnitzer A., Goldberg B., McGinn T., Davidson K.W., Barish M.A., Qiu M., Zhang M., Goldin M., Matsagkas M., Arnaoutoglou E., Spyropoulos A.C. (2021)
      Thromboembolic events, including venous thromboembolism (VTE) and arterial thromboembolism (ATE), and mortality from subclinical thrombotic events occur frequently in coronavirus disease 2019 (COVID-19) inpatients. Whether ...

    • Prevalence and Overlap of Potential Embolic Sources in Patients With Embolic Stroke of Undetermined Source 

      Ntaios G., Perlepe K., Lambrou D., Sirimarco G., Strambo D., Eskandari A., Karagkiozi E., Vemmou A., Koroboki E., Manios E., Makaritsis K., Vemmos K., Michel P. (2019)
      Background: We aimed to assess the prevalence and degree of overlap of potential embolic sources (PES) in patients with embolic stroke of undetermined source (ESUS). Methods and Results: In a pooled data set derived from ...

    • The putative interplay between DJ-1/NRF2 and Dimethyl Fumarate: A potentially important pharmacological target 

      Vavougios G., Zarogiannis S.G., Doskas T. (2018)
      Recent research has outlined that Dimethyl Fumarate (DMF) functions as a gene regulator via multiple pathways, critical among which is the NRF2 cytoprotective cascade. PARK7/DJ-1 is a multifunctional protein that acts as ...

    • A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures 

      Schemitsch E.H., Miclau T., Karachalios T., Nowak L.L., Sancheti P., Poolman R.W., Caminis J., Daizadeh N., Dent-Acosta R.E., Egbuna O., Chines A., Maddox J., Grauer A., Bhandari M. (2020)
      Background:Romosozumab is a bone-forming antibody that increases bone formation and decreases bone resorption. We conducted a double-blinded, randomized, phase-2, dose-finding trial to evaluate the effect of romosozumab ...

    • Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group 

      Fountzilas E., Lampaki S., Koliou G.-A., Koumarianou A., Levva S., Vagionas A., Christopoulou A., Laloysis A., Psyrri A., Binas I., Mountzios G., Kentepozidis N., Kotsakis A., Saloustros E., Boutis A., Nikolaidi A., Fountzilas G., Georgoulias V., Chrysanthidis M., Kotteas E., Vo H., Tsiatas M., Res E., Linardou H., Daoussis D., Bompolaki I., Andreadou A., Papaxoinis G., Spyratos D., Gogas H., Syrigos K.N., Bafaloukos D. (2022)
      Background: Data on the safety and efficacy of immune checkpoint inhibitors (ICI) in patients with concurrent autoimmune diseases (AID) are limited. Methods: We performed a retrospective multicenter review of medical records ...

    • Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study 

      Paciaroni M., Caso V., Agnelli G., Mosconi M.G., Giustozzi M., Seiffge D.J., Engelter S.T., Lyrer P., Polymeris A.A., Kriemler L., Zietz A., Putaala J., Strbian D., Tomppo L., Michel P., Strambo D., Salerno A., Remillard S., Buehrer M., Bavaud O., Vanacker P., Zuurbier S., Yperzeele L., Loos C.M.J., Cappellari M., Emiliani A., Zedde M., Abdul-Rahim A., Dawson J., Cronshaw R., Schirinzi E., Del Sette M., Stretz C., Kala N., Reznik M., Schomer A., Grory B.M., Jayaraman M., Mctaggart R., Yaghi S., Furie K.L., Masotti L., Grifoni E., Toni D., Risitano A., Falcou A., Petraglia L., Lotti E.M., Padroni M., Pavolucci L., Lochner P., Silvestrelli G., Ciccone A., Alberti A., Venti M., Traballi L., Urbini C., Kargiotis O., Rocco A., Diomedi M., Marcheselli S., Caliandro P., Zauli A., Reale G., Antonenko K., Rota E., Tassinari T., Saia V., Palmerini F., Aridon P., Arnao V., Monaco S., Cottone S., Baldi A., D'Amore C., Ageno W., Pegoraro S., Ntaios G., Sagris D., Giannopoulos S., Kosmidou M., Ntais E., Romoli M., Pantoni L., Rosa S., Bertora P., Chiti A., Canavero I., Saggese C.E., Plocco M., Giorli E., Palaiodimou L., Bakola E., Tsivgoulis G., Bandini F., Gasparro A., Terruso V., Mannino M., Pezzini A., Ornello R., Sacco S., Popovic N., Scoditti U., Genovese A., Denti L., Flomin Y., Mancuso M., Ferrari E., Caselli M.C., Ulivi L., Giannini N., De Marchis G.M. (2022)
      BACKGROUND: In patients with atrial fibrillation who suffered an ischemic stroke while on treatment with nonvitamin K antagonist oral anticoagulants, rates and determinants of recurrent ischemic events and major bleedings ...